Jobs / United States / Novartis Pharmaceuticals Corporation
Director, Medical Value & Enablement
Novartis Pharmaceuticals Corporation · 🇺🇸 East Hanover
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Novartis Pharmaceuticals Corporation paid sponsored hires in similar roles7 certified filings for “Director, Resource Optimization Commercial” (Medical and Health Services Managers) in NJ: $183k–$223k, median $223k. Most were filed at wage level IV (67%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Novartis Pharmaceuticals Corporation
The US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Novartis Pharmaceuticals Corporation →
About the role
Job Description Summary The Director, Medical Value & Enablement (MVE) is a highly autonomous strategic advisor, thought leader, and transformation architect within US Medical Affairs. Operating with minimal day-to-day leadership oversight, the Director independently identifies enterprise-critical opportunities, frames complex and ambiguous challenges, develops original points of view, and creates executive-ready strategies from concept to measurable value realization. The Director is expected to lead through expertise, influence, and sound judgment rather than positional authority. The role rapidly synthesizes external trends, internal data, stakeholder insight, and emerging AI capabilities to challenge assumptions, generate differentiated solutions, and make clear recommendations. Success requires consulting-level problem solving, exceptional learning agility, disciplined experimentation, and the confidence to independently draft, design, build, and advance high-impact work without waiting for detailed direction. The role retains strategic accountability at the MST, Disease Cluster, portfolio, and/or COE level while orchestrating execution across NOCCs, and remains accountable for strategic coherence, decision quality, fit-for-purpose design, stakeholder adoption, capability uplift, and sustained business, organizational, and patient-impact value. Job Description Key Responsibilities: Strategic Planning and Advisory · Operate as a trusted, highly autonomous advisor to the respective Vice President and leadership team, setting the strategic agenda within the role’s mandate and advancing priorities with minimal day-to-day oversight. · Independently frames ambiguous business questions, identify root causes, establish hypotheses, and develops original, evidence-based points of view that challenge conventional thinking and expand strategic options. · Lead strategic planning across MSTs, Disease Clusters, portfolios, and/or COEs, translating enterprise and US Medical Affairs priorities into clear choices, integrated plans, decision rights, and measurable outcomes. · Draft and create high-quality strategies, business cases, roadmaps, frameworks, and executive recommendations from a blank page if required, using subject-matter expertise, sound judgment, relevant data, and rapid iteration. · Anticipate emerging needs and risks, make timely recommendations with incomplete information, and maintain momentum in fast-changing environments without waiting for detailed direction. Transformation Leadership and Strategic Orchestration · Own and orchestrate complex, cross-functional transformations from opportunity identification and strategy through design, activation, adoption, and multi-year value realization. · Design future-state operating models, decision rights, capability architecture, and implementation roadmaps that introduce leading practice while remaining practical, scalable, and fit for Medical Affairs. · Apply fit-for-purpose, proven transformation, capability, and change methodologies including design, capability maturity assessments, and behavior-change approaches beyond applying models mechanically. · Establish clear strategic hypotheses, stage gates, dependencies, risk boundaries, and course-correction mechanisms to accelerate progress while managing quality, compliance, and enterprise risk. · Mobilize senior leaders and cross-functional partners around outcomes, choices, accountabilities, and critical decisions as a credible thought leader and integrator beyond tactical execution. Value Realization and Impact Measurement · Define the value thesis for each priority, linking strategic choices and activities to stakeholder outcomes, organizati